242 related articles for article (PubMed ID: 34004159)
1. RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness.
Benítez S; Cordero A; Santamaría PG; Redondo-Pedraza J; Rocha AS; Collado-Solé A; Jimenez M; Sanz-Moreno A; Yoldi G; Santos JC; De Benedictis I; Gómez-Aleza C; Da Silva-Álvarez S; Troulé K; Gómez-López G; Alcazar N; Palmero I; Collado M; Serrano M; Gonzalez-Suarez E
Dev Cell; 2021 Jun; 56(12):1727-1741.e7. PubMed ID: 34004159
[TBL] [Abstract][Full Text] [Related]
2. RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.
Palafox M; Ferrer I; Pellegrini P; Vila S; Hernandez-Ortega S; Urruticoechea A; Climent F; Soler MT; Muñoz P; Viñals F; Tometsko M; Branstetter D; Dougall WC; González-Suárez E
Cancer Res; 2012 Jun; 72(11):2879-88. PubMed ID: 22496457
[TBL] [Abstract][Full Text] [Related]
3. RANK as a therapeutic target in cancer.
González-Suárez E; Sanz-Moreno A
FEBS J; 2016 Jun; 283(11):2018-33. PubMed ID: 26749530
[TBL] [Abstract][Full Text] [Related]
4. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
Gonzalez-Suarez E; Jacob AP; Jones J; Miller R; Roudier-Meyer MP; Erwert R; Pinkas J; Branstetter D; Dougall WC
Nature; 2010 Nov; 468(7320):103-7. PubMed ID: 20881963
[TBL] [Abstract][Full Text] [Related]
5. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
6. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
Wang C; Bai F; Zhang LH; Scott A; Li E; Pei XH
Breast Cancer Res; 2018 Jul; 20(1):74. PubMed ID: 29996906
[TBL] [Abstract][Full Text] [Related]
7. RANKL and RANK: From Mammalian Physiology to Cancer Treatment.
Rao S; Cronin SJF; Sigl V; Penninger JM
Trends Cell Biol; 2018 Mar; 28(3):213-223. PubMed ID: 29241686
[TBL] [Abstract][Full Text] [Related]
8. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
9. RANKL/RANK control Brca1 mutation- .
Sigl V; Owusu-Boaitey K; Joshi PA; Kavirayani A; Wirnsberger G; Novatchkova M; Kozieradzki I; Schramek D; Edokobi N; Hersl J; Sampson A; Odai-Afotey A; Lazaro C; Gonzalez-Suarez E; Pujana MA; Cimba F; Heyn H; Vidal E; Cruickshank J; Berman H; Sarao R; Ticevic M; Uribesalgo I; Tortola L; Rao S; Tan Y; Pfeiler G; Lee EY; Bago-Horvath Z; Kenner L; Popper H; Singer C; Khokha R; Jones LP; Penninger JM
Cell Res; 2016 Jul; 26(7):761-74. PubMed ID: 27241552
[TBL] [Abstract][Full Text] [Related]
10. The RANK Pathway in Advanced Breast Cancer: Does Src Play a Role?
Li R; Zhang K; Penedo TL; Kragel CP; Grizzle WE; Hameed O; Siegal GP; Wei S
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):42-50. PubMed ID: 26200837
[TBL] [Abstract][Full Text] [Related]
11. RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation.
Yoldi G; Pellegrini P; Trinidad EM; Cordero A; Gomez-Miragaya J; Serra-Musach J; Dougall WC; Muñoz P; Pujana MA; Planelles L; González-Suárez E
Cancer Res; 2016 Oct; 76(19):5857-5869. PubMed ID: 27480274
[TBL] [Abstract][Full Text] [Related]
12. RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.
Azim HA; Peccatori FA; Brohée S; Branstetter D; Loi S; Viale G; Piccart M; Dougall WC; Pruneri G; Sotiriou C
Breast Cancer Res; 2015 Feb; 17():24. PubMed ID: 25849336
[TBL] [Abstract][Full Text] [Related]
13. p16INK4a suppresses BRCA1-deficient mammary tumorigenesis.
Scott A; Bai F; Chan HL; Liu S; Ma J; Slingerland JM; Robbins DJ; Capobianco AJ; Pei XH
Oncotarget; 2016 Dec; 7(51):84496-84507. PubMed ID: 27811360
[TBL] [Abstract][Full Text] [Related]
14. Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis.
Pellegrini P; Cordero A; Gallego MI; Dougall WC; Muñoz P; Pujana MA; Gonzalez-Suarez E
Stem Cells; 2013 Sep; 31(9):1954-65. PubMed ID: 23766243
[TBL] [Abstract][Full Text] [Related]
15. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives.
Infante M; Fabi A; Cognetti F; Gorini S; Caprio M; Fabbri A
J Exp Clin Cancer Res; 2019 Jan; 38(1):12. PubMed ID: 30621730
[TBL] [Abstract][Full Text] [Related]
16. RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis.
Schramek D; Sigl V; Penninger JM
Trends Endocrinol Metab; 2011 May; 22(5):188-94. PubMed ID: 21470874
[TBL] [Abstract][Full Text] [Related]
17. Aurora A overexpression induces cellular senescence in mammary gland hyperplastic tumors developed in p53-deficient mice.
Zhang D; Shimizu T; Araki N; Hirota T; Yoshie M; Ogawa K; Nakagata N; Takeya M; Saya H
Oncogene; 2008 Jul; 27(31):4305-14. PubMed ID: 18372918
[TBL] [Abstract][Full Text] [Related]
18. RANKL inhibition: a promising novel strategy for breast cancer treatment.
González-Suárez E
Clin Transl Oncol; 2011 Apr; 13(4):222-8. PubMed ID: 21493182
[TBL] [Abstract][Full Text] [Related]
19. Wnt signaling, stem cells, and the cellular origin of breast cancer.
Lindvall C; Bu W; Williams BO; Li Y
Stem Cell Rev; 2007 Jun; 3(2):157-68. PubMed ID: 17873348
[TBL] [Abstract][Full Text] [Related]
20. Role of the RANK/RANKL pathway in breast cancer.
Kiesel L; Kohl A
Maturitas; 2016 Apr; 86():10-6. PubMed ID: 26921922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]